Baseline serum adrenal androgens are prognostic and predictive of overall survival (OS) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC): Results of the COU-AA-301 phase 3 randomized trial Meeting Abstract
| Authors: | Ryan, C.; Li, J. H.; Kheoh, T.; Scher, H. I.; Molina, A. |
| Abstract Title: | Baseline serum adrenal androgens are prognostic and predictive of overall survival (OS) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC): Results of the COU-AA-301 phase 3 randomized trial |
| Meeting Title: | 103rd Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 72 |
| Issue: | 8 Suppl. |
| Meeting Dates: | 2012 Mar 31-Apr 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2012-04-01 |
| Language: | English |
| ACCESSION: | WOS:000209701601393 |
| DOI: | 10.1158/1538-7445.am2012-lb-434 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LB-434 -- Source: Wos |
